Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.

[1]  S. Rhee,et al.  An efficient plasmid vector for constitutive high-level expression of foreign genes in Escherichia coli , 2009, Biotechnology Letters.

[2]  M. Gómez-Lim,et al.  Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli , 2009, Virology Journal.

[3]  Tae-Geum Kim,et al.  Immunogenicity of a Cholera Toxin B Subunit Porphyromonas gingivalis Fimbrial Antigen Fusion Protein Expressed in E. coli , 2009, Molecular biotechnology.

[4]  T. Mor,et al.  Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. , 2009, Plant biotechnology journal.

[5]  C. Betterle,et al.  Preparation and Testing of Diabetes Autoantibody Controls , 2008, Annals of the New York Academy of Sciences.

[6]  S. Ramalingam,et al.  Rare codon priority and its position specificity at the 5' of the gene modulates heterologous protein expression in Escherichia coli. , 2008, Biochemical and biophysical research communications.

[7]  Johnny Ludvigsson,et al.  GAD treatment and insulin secretion in recent-onset type 1 diabetes. , 2008, The New England journal of medicine.

[8]  Amit Ghosh,et al.  Expression of accessory colonization factor subunit A (ACFA) of Vibrio cholerae and ACFA fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). , 2008, Journal of biotechnology.

[9]  Amit Ghosh,et al.  Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum) , 2008, Plant Cell Reports.

[10]  Tracey A Ruhlman,et al.  Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice. , 2007, Plant biotechnology journal.

[11]  T. Park,et al.  Expression of recombinant human growth hormone in a soluble form in Escherichia coli by slowing down the protein synthesis rate. , 2007, Journal of microbiology and biotechnology.

[12]  Yongfeng Jin,et al.  Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm. , 2007, Vaccine.

[13]  Tae-Geum Kim,et al.  Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants. , 2006, Protein expression and purification.

[14]  A. Jevnikar,et al.  Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants , 2006, Plant Cell Reports.

[15]  M. Estes,et al.  Synthesis and assembly of a cholera toxin B subunit-rotavirus VP7 fusion protein in transgenic potato , 2005, Molecular biotechnology.

[16]  Yongfeng Jin,et al.  Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes. , 2005, Journal of biotechnology.

[17]  S. Michalek,et al.  Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis. , 2005, Vaccine.

[18]  A. Jevnikar,et al.  Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Petersen,et al.  Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes , 2003, Clinical and experimental immunology.

[20]  J. Petersen,et al.  The Cholera Toxin B Subunit is a Mucosal Adjuvant for Oral Tolerance Induction in Type 1 Diabetes , 2003, Scandinavian journal of immunology.

[21]  C. Czerkinsky,et al.  Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA , 2003, Expert review of vaccines.

[22]  C. Czerkinsky,et al.  Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses 1 , 2003, The Journal of Immunology.

[23]  P. Ho,et al.  Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. , 2002, Protein expression and purification.

[24]  E. Sercarz,et al.  Regulatory and Effector CD4 T Cells in Nonobese Diabetic Mice Recognize Overlapping Determinants on Glutamic Acid Decarboxylase and Use Distinct Vβ Genes1 , 2001, The Journal of Immunology.

[25]  H. Weiner,et al.  Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. , 2001, Journal of autoimmunity.

[26]  M. Isaka,et al.  Cytokine Responses to Recombinant Cholera Toxin B Subunit Produced by Bacillus brevis as a Mucosal Adjuvant , 2001, Microbiology and immunology.

[27]  C. Czerkinsky,et al.  Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit. , 2000, Clinical immunology.

[28]  C. Czerkinsky,et al.  Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  Keisuke Sato,et al.  Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice , 2000, Immunogenetics.

[30]  H. Kolb,et al.  Induction of Tolerance in Macrophages by Cholera Toxin B Chain , 2000, Pathobiology.

[31]  N. Glaichenhaus,et al.  Selective tolerization of Th1‐like cells after nasal administration of a cholera toxoid‐LACK conjugate , 1998, European journal of immunology.

[32]  A. Jevnikar,et al.  Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance , 1997, Nature Medicine.

[33]  J. Petersen,et al.  A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Li,et al.  Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone. , 1996, International immunology.

[35]  T. Olsson,et al.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Atkinson,et al.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes , 1996, The Journal of experimental medicine.

[37]  H. Weiner,et al.  Oral tolerance , 2011, Immunological reviews.

[38]  C. Czerkinsky,et al.  Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Bazin,et al.  Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit , 1992, European journal of immunology.

[40]  Th. Mandel,et al.  Progression From Insulitis to β-Cell Destruction in NOD Mouse Requires L3T4+ T-Lymphocytes , 1988, Diabetes.

[41]  S. Korban,et al.  Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. , 2009, The Plant journal : for cell and molecular biology.

[42]  R. Uibo,et al.  GAD65 autoimmunity-clinical studies. , 2008, Advances in immunology.

[43]  Alfred D. Eaton,et al.  Oral tolerance. , 2000, American journal of respiratory and critical care medicine.